Table 3.
General Liner Mixed Model Analyses Showing the Effects of Medication Type, Oral vs Injectable, and Intervention Type, Cognitive Training vs Healthy Behaviors Training on SANS and BPRS Negative Symptoms
| SANS Expressive |
SANS Experiential |
Anhedonia | Apathy | Alogia | Affect | BPRS-Blunted | BPRS-Motor Retardation |
BPRS-Emotional Withdrawal |
|
|---|---|---|---|---|---|---|---|---|---|
| CT/HBT | F(1,88)=6.7, p=.01 | F(1,89)=4.1, p=.05 | F(1,91)=3.4, p=.07 | F(1,93)=3.1, p=.08 | F(1,93)=6.5, p=.01 | F(1,89)=5.8, p=.02 | F(1,90)=5.6, p=.02 | F(1,104)= 4.0, p=.05 | F(1,111)= 2.9, p=.09 |
| Medication (med) | F(1,88)=.2, p=.70 | F(1,89)=1.3, p=.27 | F(1,91)=.5, p=.49 | F(1,93)=3.1, p=.08 | F(1,93)=.9, p=.34 | F(1,89)=0.0, p=.84 | F(1,90)=0.0, p=.96 | F(1,104)= 0.2, p=.64 | F(1,111)= 0.6, p=.44 |
| Time | F(1,1117)= 42.6, p<.01 | F(1,1118)= 71.6, p<.01 | F(1,1119)= 46.0, p<.01 | F(1.93)=47.6, p<.01 | F(1,1121)= 20.5, p<.01 | F(1,1118)= 46.7, p<.01 | F(1,1125)= 24.3, p<.01 | F(1,1132)= 33.0, p<.01 | F(1,1136)= 3.0, p=.08 |
| Medication*time | F(1,1117)= 1.2, p=.27 | F(1,1118)= .45, p=.50 | F(1,1119)= .76, p=.38 | F(1,1120)= .1, p=.76 | F(1,1121)= .1, p=.81 | F(1,1118)= 3.0, p=.08 | F(1,1125)= 0.0, p=.97 | F(1,1132)= 2.4, p=.12 | F(1,1136)= 0.1, p=.79 |
| CT/HBT*time | F(1,1117)= 10.7, p<.01 | F(1,1118)= 11.3, p<.01 | F(1,1119)= 12.4, p<.01 | F(1,1120)= 4.3, p=.04 | F(1,1121)= 4.4, p=.04 | F(1,1118)= 13.3, p<.01 | F(1,1125)= 4.7, p=.03 | F(1,1132)= 0.0, p=.95 | F(1,1136)= .01, p=.78 |
| CT/HBT*med | F(1,88)=.38, p=.54 | F(1,89)=3.7, p=.06 | F(1,91)=1.2, p=.28 | F(1,93)=5.3, p=.02 | F(1,93)=.3, p=.62 | F(1,89)=0.5, p=.50 | F(1,90)=.06, p=.80 | F(1,104)= 2.5, p=.12 | F(1,110)= 3.7, p=.06 |
| CT/HBT*med*time | F(1,1117)= .18, p=.67 | F(1,1118)= .55, p=.46 | F(1,1119)= 1.6, p=.20 | F(1,1120)= 4.4, p=.04 | F(1,1121)= .30, p=.58 | F(1,1118)= 1.7, p=.19 | F(1,1125)= 0.0, p=.83 | F(1,1132)= 0.1, p=.80 | F(1,1136)= 1.2, p=.28 |